Topic
precision medicine
7 stories related to this topic, newest first.
forbes.comworld39 days ago
Startup Develops System To Track Cancer Treatment Response In Real Time
A startup valued at $250 million has created technology that monitors how tumors respond to cancer treatments as they occur. The system aims to provide physicians with immediate data on treatment effectiveness rather than waiting for traditional scans. Forbes reported the develop…
FO
Substrate placeholder — needs reviewfinance72 days ago
Revolution Medicines Advances Testing of Pancreatic Cancer Treatment Pill
Revolution Medicines is conducting clinical trials for a pill targeting pancreatic cancer. The treatment aims to address a disease with limited effective options. CNBC reported on the company's latest developments in this area.
Substrate placeholder — needs reviewscience73 days ago
Asia Summit on Global Health Scheduled for May 2026 in Hong Kong
The Asia Summit on Global Health (ASGH) 2026 will take place on May 11-12 in Hong Kong. The event will cover topics including gene and cell therapies, precision medicine, smart ageing, artificial intelligence, and digital health. Organizers invite participants to register for the…
NE
sciencenews.orgscience74 days ago
Genetic Variants Linked to Weight Loss Outcomes and Side Effects from GLP-1 Drugs
A study published in Nature identifies variations in two genes associated with greater weight loss and increased side effects from GLP-1 receptor agonist drugs like Wegovy and Mounjaro. The research, based on data from 15,000 to nearly 28,000 23andMe users, shows modest genetic i…
ST
neurosciencenews.comscience74 days ago
Genetic Variants Linked to Weight Loss Outcomes on GLP-1 Drugs in New Study
A study published in Nature identifies variations in two genes associated with greater weight loss and side effects from GLP-1 receptor agonist drugs like Wegovy and Mounjaro. The research, based on data from 15,000 to 28,000 users, shows these genetic factors contribute modestly…
BU
ST
Substrate placeholder — needs reviewscience75 days ago
Tumor Mutations Often Unidentified, Limiting Use of Advanced Targeted Therapies
Many advanced targeted therapies remain unused because mutations in tumors are not identified through testing. According to STAT News, this gap affects patient treatment options in oncology. The issue highlights challenges in precision medicine implementation.
ST
Substrate placeholder — needs reviewscience75 days ago
Many Cancer Patients Not Receiving Genomic Testing Despite Treatment Advances
A report indicates that a significant number of cancer patients are not undergoing genomic testing, which can identify targeted therapies. This testing analyzes tumor DNA to match treatments to specific genetic mutations. The gap persists even as precision medicine options expand…
ST